{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-24-000150","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.454580+00:00","generated_at":"2026-05-31T09:45:51.191128+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Immunovant stockholders elect directors, ratify auditor, approve compensation at 2024 annual meeting","bullets":["Three directors (Salzmann, Migausky, Hughes) elected with over 97M votes for each, ~6.5M broker non-votes.","Ernst & Young ratified as auditor for FY ending March 31, 2025: 138,241,628 for, 16,740 against.","Non-binding advisory approval of named executive officer compensation: 128,494,310 for, 3,249,170 against.","Approximately 95% of eligible shares (138.3M) represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-24-000150","json":"https://secwatch.observer/filing/0001764013-24-000150.json","markdown":"https://secwatch.observer/filing/0001764013-24-000150.md","text":"https://secwatch.observer/filing/0001764013-24-000150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000150/0001764013-24-000150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000150/imvt-20240812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:45:51.191128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}